Snapshot from Aug 20, 2026 at 07:00 UTC. For live data and tracking: View Live
Business executive appointment

Masimo Appoints Tim Benner President

Analysis based on 8 articles · First reported Aug 03, 2026 · Last updated Aug 04, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The appointment is a routine leadership change within a subsidiary of Danaher Corporation, likely to have minimal direct impact on Danaher's stock price. It signals continuity and stability in Masimo's management following its acquisition by Danaher, which may be viewed slightly positively by investors.

Medical Devices Healthcare

Masimo, a Danaher company and specialty diagnostics innovator, announced the appointment of Tim Benner as President, effective August 3, 2026. Benner, who joined Masimo in June 2025, previously served as Chief Marketing and Strategy Officer and most recently as Chief Commercial Officer. He brings over 30 years of executive leadership in medical technology, with prior roles at Edwards Lifesciences, Abbott, Terumo, Inari Medical/Stryker, and Masimo. Julie Sawyer Montgomery, CEO Designate of Danaher Corporation, expressed confidence in Benner's leadership. As President, Benner will lead Masimo's global business, focusing on innovation, customer partnerships, and commercial growth.

80 Masimo appointed Tim Benner
stock
Masimo is the subject of the appointment, gaining a new President to lead its global business. The move is part of its integration as a Danaher company and is expected to support its growth and innovation strategy.
Importance 100.0 Sentiment 10.0
per
Tim Benner is promoted to President of Masimo, a significant career advancement. His leadership is expected to drive Masimo's commercial growth and innovation, enhancing his professional standing.
Importance 100.0 Sentiment 20.0
stock
Danaher, as the parent company, endorsed the appointment, reflecting its confidence in Masimo's leadership. The change is part of Danaher's ongoing integration of Masimo and is unlikely to materially affect Danaher's financials.
Importance 80.0 Sentiment 10.0
per
Julie Sawyer Montgomery, as CEO Designate of Danaher, publicly supported Benner's appointment, reinforcing her role in overseeing Masimo's integration. The event has minimal direct impact on her.
Importance 30.0 Sentiment 5.0
stock
Edwards Lifesciences is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Importance 10.0 Sentiment 0.0
stock
Abbott is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Importance 10.0 Sentiment 0.0
stock
Terumo is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Importance 10.0 Sentiment 0.0
stock
Inari Medical is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Importance 10.0 Sentiment 0.0
stock
Stryker is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.